The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Hydrogen Peroxide Is Essential for Estrogen-Deficiency Bone Loss and Osteoclast Formation
Open accessAbstract
We recently found that estrogen deficiency leads to a lowering of thiol antioxidant defenses in rodent bone. Moreover, administration of agents that increase the concentration in bone of glutathione, the main intracellular antioxidant, prevented estrogen-deficiency bone loss, whereas depletion of glutathione by buthionine sulfoximine administration provoked substantial bone loss. To analyze further the mechanism by which antioxidant defenses modulate bone loss, we have now compared expression of the known antioxidant enzymes in osteoclasts. We found that glutathione peroxidase 1 (Gpx), the enzyme primarily responsible for the intracellular degradation of hydrogen peroxide, is overwhelmingly the predominant antioxidant enzyme expressed by osteoclasts and that its expression was increased in bone marrow macrophages by receptor activator of nuclear factor-kappaB ligand (RANKL) and in osteoclasts by 17beta-estradiol. We therefore tested the effect of overexpression of Gpx in osteoclasts by stable transfection of RAW 264.7 (RAW) cells, which are capable of osteoclastic differentiation in response to RANKL, with a Gpx-expression construct. Osteoclast formation was abolished. The Gpx expression construct also suppressed RANKL-induced nuclear factor-kappaB activation and increased resistance to oxidation of dihydrodichlorofluorescein by exogenous hydrogen peroxide. We therefore tested the role of hydrogen peroxide in the loss of bone caused by estrogen deficiency by administering pegylated catalase to mice. We found that catalase prevented ovariectomy-induced bone loss. These results suggest that hydrogen peroxide is the reactive oxygen species responsible for signaling the bone loss of estrogen deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Schreck, R., Rieber, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,816
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
p53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · cited 1×
“Furthermore, osteoporosis has recently been noted in two mouse models of premature aging associated with oxidative damage (31, 32) in which osteopenia is presumed to be the consequence of oxidative damage.”
BackgroundLam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440 · cited 1×
“Recently it was shown that TNF synergizes strongly with RANKL for osteoclast formation and activation (28, 29) and that mice lacking TNF signaling do not lose bone after ovariectomy (27).”
BackgroundRequirement for NF-κB in osteoclast and B-cell development
Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E. W., Brown, K. D., Leonardi, A., Tran, T., Boyce, B. F., & Siebenlist, U. (1997) · Genes & Development · doi:10.1101/gad.11.24.3482 · Cited by 996
Garrett, I. R., Boyce, B. F., Oreffo, R. O., Bonewald, L., Poser, J., & Mundy, G. R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114485 · Cited by 806
Hydrogen peroxide as second messenger in lymphocyte activation
Reth, M. (2002) · Nature Immunology · doi:10.1038/ni1202-1129 · Cited by 779
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β
Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., et al. (2002) · Nature · doi:10.1038/416744a · Cited by 717
A crucial role for thiol antioxidants in estrogen-deficiency bone loss
Lean, J. M., Davies, J. T., Fuller, K., Jagger, C. J., Kirstein, B., Partington, G. A., Urry, Z., & Chambers, T. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18859 · Cited by 547
Self-citationPremature Aging in Mice Deficient in DNA Repair and Transcription
de Boer, J., Andressoo, J. O., de Wit, J., Huijmans, J., Beems, R. B., van Steeg, H., Weeda, G., van der Horst, G. T. J., van Leeuwen, W., Themmen, A. P. N., et al. (2002) · Science · doi:10.1126/science.1070174 · Cited by 545
Maggio, D., Barabani, M., Pierandrei, M., Polidori, M. C., Catani, M., Mecocci, P., Senin, U., Pacifici, R., & Cherubini, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021496 · Cited by 531
Roggia, C., Gao, Y., Cenci, S., Weitzmann, M. N., Toraldo, G., Isaia, G., & Pacifici, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251534698 · Cited by 513
Reversal of Bone Loss in Mice by Nongenotropic Signaling of Sex Steroids
Kousteni, S., Chen, J.-R., Bellido, T., Han, L., Ali, A. A., O'Brien, C. A., Plotkin, L., Fu, Q., Mancino, A. T., Wen, Y., et al. (2002) · Science · doi:10.1126/science.1074935 · Cited by 420
Kitazawa, R., Kimble, R. B., Vannice, J. L., Kung, V. T., & Pacifici, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117606 · Cited by 336
Fuller, K., Murphy, C., Kirstein, B., Fox, S. W., & Chambers, T. J. (2002) · Endocrinology · doi:10.1210/endo.143.3.8701 · Cited by 335
Self-citationChow, J., Tobias, J. H., Colston, K. W., & Chambers, T. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115588 · Cited by 269
Self-citationThe Inactivation Mechanism of Low Molecular Weight Phosphotyrosine-protein Phosphatase by H2O2
Caselli, A., Marzocchini, R., Camici, G., Manao, G., Moneti, G., Pieraccini, G., & Ramponi, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32554 · Cited by 213
Multiple redox regulation in NF-kappaB transcription factor activation.
Piette, J. G., Piret, B., Bonizzi, G., Schoonbroodt, S., Merville, M., Legrand-Poels, S., & Bours, V. (1997) · PubMed · Cited by 212
Stimulation of osteoclastic bone resorption by hydrogen peroxide
Bax, B. E., Alam, A. S. M. T., Banerji, B., Bax, C. M. R., Bevis, P. J. R., Stevens, C. R., Moonga, B. S., Blake, D. R., & Zaidi, M. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80311-0 · Cited by 202
Wani, M. R. (1999) · Endocrinology · doi:10.1210/en.140.4.1927 · Cited by 172
Steinbeck, M. J., Appel, W. H., Verhoeven, A. J., & Karnovsky, M. J. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.3.765 · Cited by 171
Lean, J. M., Murphy, C., Fuller, K., & Chambers, T. J. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10319 · Cited by 152
Self-citationOxidants Painting the Cysteine Chapel
Xu, D. L., Rovira, I. I., & Finkel, T. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00132-6 · Cited by 148
Participation of oxidative stress in the process of osteoclast differentiation
Suda, N., Morita, I., Kuroda, T., & Murota, S. (1993) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(93)90116-p · Cited by 144
The Role of Reactive Oxygen Intermediates in Osteoclastic Bone Resorption
Hall, T. J., Schaueblin, M., Jeker, H., Fuller, K., & Chambers, T. J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1184 · Cited by 108
Self-citationMaternal administration of superoxide dismutase and catalase in phenytoin teratogenicity1
Winn, L. M., & Wells, P. G. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00193-2 · Cited by 102
[5] Detection of intracellular reactive oxygen species in cultured cells using fluorescent probes
Nègre‐Salvayre, A., Augè, N., Duval, C., Robbesyn, F., Thiers, J., Nazzal, D., Benoist, H., & Salvayre, R. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)52007-3 · Cited by 85
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Osteoclast lineage commitment of bone marrow precursors through expression of membrane-bound TRANCE
Lean, J. M., Matsuo, K., Fox, S. W., Fuller, K., Gibson, F. M., Draycott, G. S., Wani, M. R., Bayley, K. E., Wong, B. R., Choi, Y., et al. (2000) · Bone · doi:10.1016/s8756-3282(00)00306-9 · Cited by 60
Self-citation
Cited by
The complex role of estrogens in inflammation
Straub, R. H. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0001 · Cited by 1,950
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779
Manolagas, S. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0024 · Cited by 1,200
Estrogen deficiency and bone loss: an inflammatory tale
Weitzmann, M. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28550 · Cited by 990
Oxidative stress in bone remodeling: role of antioxidants
Domazetovic, V (2017) · Clinical Cases in Mineral and Bone Metabolism · doi:10.11138/ccmbm/2017.14.1.209 · Cited by 758
“Thereafter, the turnover of the bone remodeling process increases and this is indicated by an increase in RANKL / OPG ratio, that is, in fact, an index of the intensity of bone resorption (18, 49).”
BackgroundInfluential
Metadata
- Authors
- Lean, J. M., Jagger, C. J., Kirstein, B., Fuller, K., & Chambers, T. J.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-02-01
- Volume
- 146
- Issue
- 2
- Pages
- 728-735
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2066365078
- Cited by
- 333
- References
- 32
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.